Form 8-K - Current report:
SEC Accession No. 0000950170-25-064531
Filing Date
2025-05-06
Accepted
2025-05-06 16:30:30
Documents
56
Period of Report
2025-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prld-20250506.htm   iXBRL 8-K 53914
2 EX-99.1 prld-ex99_1.htm EX-99.1 191604
3 EX-99.2 prld-ex99_2.htm EX-99.2 47789
4 GRAPHIC img268059179_0.jpg GRAPHIC 19947
5 GRAPHIC prld-ex99_2s1.jpg GRAPHIC 451848
6 GRAPHIC prld-ex99_2s2.jpg GRAPHIC 686517
7 GRAPHIC prld-ex99_2s3.jpg GRAPHIC 349647
8 GRAPHIC prld-ex99_2s4.jpg GRAPHIC 355387
9 GRAPHIC prld-ex99_2s5.jpg GRAPHIC 527402
10 GRAPHIC prld-ex99_2s6.jpg GRAPHIC 278585
11 GRAPHIC prld-ex99_2s7.jpg GRAPHIC 468456
12 GRAPHIC prld-ex99_2s8.jpg GRAPHIC 317645
13 GRAPHIC prld-ex99_2s9.jpg GRAPHIC 395718
14 GRAPHIC prld-ex99_2s10.jpg GRAPHIC 368221
15 GRAPHIC prld-ex99_2s11.jpg GRAPHIC 404820
16 GRAPHIC prld-ex99_2s12.jpg GRAPHIC 390136
17 GRAPHIC prld-ex99_2s13.jpg GRAPHIC 488280
18 GRAPHIC prld-ex99_2s14.jpg GRAPHIC 484390
19 GRAPHIC prld-ex99_2s15.jpg GRAPHIC 435293
20 GRAPHIC prld-ex99_2s16.jpg GRAPHIC 374197
21 GRAPHIC prld-ex99_2s17.jpg GRAPHIC 395688
22 GRAPHIC prld-ex99_2s18.jpg GRAPHIC 416582
23 GRAPHIC prld-ex99_2s19.jpg GRAPHIC 355999
24 GRAPHIC prld-ex99_2s20.jpg GRAPHIC 435861
25 GRAPHIC prld-ex99_2s21.jpg GRAPHIC 435336
26 GRAPHIC prld-ex99_2s22.jpg GRAPHIC 290322
27 GRAPHIC prld-ex99_2s23.jpg GRAPHIC 398135
28 GRAPHIC prld-ex99_2s24.jpg GRAPHIC 490297
29 GRAPHIC prld-ex99_2s25.jpg GRAPHIC 341688
30 GRAPHIC prld-ex99_2s26.jpg GRAPHIC 483479
31 GRAPHIC prld-ex99_2s27.jpg GRAPHIC 555672
32 GRAPHIC prld-ex99_2s28.jpg GRAPHIC 324293
33 GRAPHIC prld-ex99_2s29.jpg GRAPHIC 537333
34 GRAPHIC prld-ex99_2s30.jpg GRAPHIC 439190
35 GRAPHIC prld-ex99_2s31.jpg GRAPHIC 589773
36 GRAPHIC prld-ex99_2s32.jpg GRAPHIC 481354
37 GRAPHIC prld-ex99_2s33.jpg GRAPHIC 573461
38 GRAPHIC prld-ex99_2s34.jpg GRAPHIC 439724
39 GRAPHIC prld-ex99_2s35.jpg GRAPHIC 413331
40 GRAPHIC prld-ex99_2s36.jpg GRAPHIC 370993
41 GRAPHIC prld-ex99_2s37.jpg GRAPHIC 482726
42 GRAPHIC prld-ex99_2s38.jpg GRAPHIC 421077
43 GRAPHIC prld-ex99_2s39.jpg GRAPHIC 409341
44 GRAPHIC prld-ex99_2s40.jpg GRAPHIC 447185
45 GRAPHIC prld-ex99_2s41.jpg GRAPHIC 323409
46 GRAPHIC prld-ex99_2s42.jpg GRAPHIC 318253
  Complete submission text file 0000950170-25-064531.txt   25214255

Data Files

Seq Description Document Type Size
47 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20250506.xsd EX-101.SCH 50257
58 EXTRACTED XBRL INSTANCE DOCUMENT prld-20250506_htm.xml XML 4721
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 25917741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)